REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $843 | -99.9% | 45,659 | +6.2% | 0.10% | +18.0% |
| Q2 2022 | $594,000 | -54.7% | 42,978 | -36.1% | 0.09% | -49.4% |
| Q1 2022 | $1,311,000 | +80.6% | 67,232 | +174.4% | 0.18% | +114.6% |
| Q2 2021 | $726,000 | +60.6% | 24,498 | -19.9% | 0.08% | -27.4% |
| Q1 2020 | $452,000 | +115.2% | 30,574 | +192.5% | 0.11% | +370.8% |
| Q4 2018 | $210,000 | -48.3% | 10,451 | -29.4% | 0.02% | +20.0% |
| Q2 2018 | $406,000 | – | 14,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |